Citadel Advisors’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,000
Closed -$212K 15156
2021
Q4
$212K Sell
8,000
-15,500
-66% -$394K ﹤0.01% 11736
2021
Q3
$542K Sell
23,500
-23,400
-50% -$555K ﹤0.01% 9668
2021
Q2
$1.23M Buy
46,900
+11,500
+32% +$289K ﹤0.01% 7779
2021
Q1
$790K Buy
35,400
+8,113
+30% +$186K ﹤0.01% 8676
2020
Q4
$535K Buy
27,287
+8,487
+45% +$141K ﹤0.01% 8021
2020
Q3
$264K Buy
+18,800
New +$271K ﹤0.01% 8362
2020
Q2
Sell
-35,900
Closed -$226K 10763
2020
Q1
$226K Sell
35,900
-78,600
-69% -$1.27M ﹤0.01% 7814
2019
Q4
$2.33M Buy
114,500
+99,900
+684% +$1.87M ﹤0.01% 4157
2019
Q3
$243K Sell
14,600
-18,100
-55% -$313K ﹤0.01% 7883
2019
Q2
$538K Buy
32,700
+9,300
+40% +$179K ﹤0.01% 6716
2019
Q1
$411K Sell
23,400
-2,900
-11% -$61.7K ﹤0.01% 7117
2018
Q4
$653K Buy
+26,300
New +$874K ﹤0.01% 5983
2018
Q3
Sell
-6,300
Closed -$222K 9891
2018
Q2
$222K Buy
+6,300
New +$232K ﹤0.01% 7714
2016
Q1
Sell
-18,200
Closed -$234K 8366
2015
Q4
$234K Buy
18,200
+14,000
+333% +$170K ﹤0.01% 5588
2015
Q3
$47K Buy
4,200
+1,900
+83% +$23.2K ﹤0.01% 7633
2015
Q2
$28K Sell
2,300
-1,300
-36% -$21.6K ﹤0.01% 8002
2015
Q1
$71K Buy
3,600
+3,400
+1,700% +$71.1K ﹤0.01% 7138
2014
Q4
$4K Sell
200
-300
-60% -$4.9K ﹤0.01% 8313
2014
Q3
$8K Sell
500
-500
-50% -$8.48K ﹤0.01% 7816
2014
Q2
$18K Sell
1,000
-2,400
-71% -$41.2K ﹤0.01% 7356
2014
Q1
$58K Sell
3,400
-1,200
-26% -$18.5K ﹤0.01% 6651
2013
Q4
$71K Buy
4,600
+2,300
+100% +$32.6K ﹤0.01% 5847
2013
Q3
$43K Buy
+2,300
New +$41.6K ﹤0.01% 5877

Other funds holding TVTY

Citadel Advisors's TVTY Position: Q2 2022 in Review

Citadel Advisors sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 163,892 shares — an estimated $5.27M sold.

Citadel Advisors first reported a position in TVTY in Q3 2013 and held it in 30 quarters. The position peaked at $14.6M in Q4 2018. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • Citadel Advisors reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 163,892 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $5.27M.
  • Citadel Advisors first reported a position in Tivity Health, Inc. Common Stock in Q3 2013 and held it in 30 quarters.
  • Citadel Advisors's Tivity Health, Inc. Common Stock position peaked at $14.6M in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.